Systematic review and meta-analysis compares intravesical gemcitabine/docetaxel versus BCG for non-muscle-invasive bladder cancer
Gemcitabine and docetaxel show similar recurrence-free survival to BCG for bladder cancer
This systematic review and meta-analysis evaluated intravesical gemcitabine and docetaxel compared with Bacillus Calmette-Guérin (BCG) in pa…
A meta-analysis of 1634 patients found gemcitabine and docetaxel offered recurrence-free survival rates comparable to BCG therapy for non-mu…
Audit plus peer comparison improved documentation of tumour features and resection completeness in non-muscle-invasive bladder cancer surgery
Audit and feedback improved documentation of bladder cancer surgery details in a large trial
This cluster randomised controlled trial involved 14,915 patients undergoing transurethral resection of bladder tumour surgery across 201 si…
This large study examined whether adding peer comparison and education to standard audits changed how bladder cancer surgery was performed.
Spinal anesthesia associated with lower recurrence than general anesthesia in non-muscle invasive bladder cancer
Spinal anesthesia linked to lower bladder cancer recurrence rates in single hospital study
A single-center randomized trial of 287 patients with non-muscle invasive bladder cancer found spinal anesthesia was associated with lower 2…
Patients with early-stage bladder cancer had lower recurrence rates when spinal anesthesia was used instead of general anesthesia during tum…